4,174-Share Rule 144 Notice for Voyager Therapeutics (NASDAQ: VYGR)
Rhea-AI Filing Summary
Notice of proposed resale under Rule 144 by a holder associated with restricted stock vesting. The filing lists a planned sale of 4,174 common shares tied to restricted stock vesting on
Positive
- None.
Negative
- None.
Insights
Rule 144 notice lists a vesting-driven resale and two recent dispositions by Todd Carter.
The filing documents a restricted stock vesting event of 4,174 shares with an intended resale date of
Timing and cash‑flow treatment are described only by the listed dates; this notice signals compliance steps under resale rules rather than a company action. Subsequent SEC filings may disclose whether the shares were actually sold and any proceeds or trading methods.